BMO Capital Maintains Outperform on Boralex, Lowers Price Target to C$50
BMO Capital analyst Ben Pham maintains Boralex (TSX:BLX) with a Outperform and lowers the price target from C$53 to C$50.
Credit Suisse Downgrades Boralex to Neutral, Lowers Price Target to C$43
Credit Suisse analyst Andrew Kuske downgrades Boralex (TSX:BLX) from Outperform to Neutral and lowers the price target from C$55 to C$43.
Credit Suisse Upgrades Boralex to Outperform, Announces C$55 Price Target
Credit Suisse analyst Andrew Kuske upgrades Boralex (TSX:BLX) from Neutral to Outperform and announces C$55 price target.
Credit Suisse Downgrades Boralex to Neutral
Credit Suisse analyst Andrew Kuske downgrades Boralex (TSX:BLX) from Outperform to Neutral.